TNFRSF10A and neoplasm: TRAIL is known to be effective as a tumor-selective cytotoxic agent and signals via two pro-apoptotic death receptors, DR4 and DR5, inducing a caspase-dependent apoptotic cascade in tumor cells [5], [14], [32]–[34].